These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9412659)

  • 41. Preemptive intravenous morphine-6-glucuronide is ineffective for postoperative pain relief.
    Motamed C; Mazoit X; Ghanouchi K; Guirimand F; Abhay K; Lieutaud T; Bensaid S; Fernandez C; Duvaldestin P
    Anesthesiology; 2000 Feb; 92(2):355-60. PubMed ID: 10691220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
    Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
    J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differences in morphine analgesia: an experimental study in healthy volunteers.
    Sarton E; Olofsen E; Romberg R; den Hartigh J; Kest B; Nieuwenhuijs D; Burm A; Teppema L; Dahan A
    Anesthesiology; 2000 Nov; 93(5):1245-54; discussion 6A. PubMed ID: 11046213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays.
    Kalso E; Vainio A; Mattila MJ; Rosenberg PH; Seppälä T
    Pharmacol Toxicol; 1990 Oct; 67(4):322-8. PubMed ID: 2077525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure.
    Portenoy RK; Foley KM; Stulman J; Khan E; Adelhardt J; Layman M; Cerbone DF; Inturrisi CE
    Pain; 1991 Oct; 47(1):13-19. PubMed ID: 1771088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphine or oxycodone in cancer pain?
    Heiskanen TE; Ruismäki PM; Seppälä TA; Kalso EA
    Acta Oncol; 2000; 39(8):941-7. PubMed ID: 11207001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disposition of morphine and its glucuronide metabolites after oral and rectal administration: evidence of route specificity.
    Babul N; Darke AC
    Clin Pharmacol Ther; 1993 Sep; 54(3):286-92. PubMed ID: 8375123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers.
    Skarke C; Darimont J; Schmidt H; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2003 Jan; 73(1):107-21. PubMed ID: 12545149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.
    Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
    Pharm Res; 1998 Apr; 15(4):599-605. PubMed ID: 9587957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose.
    Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC
    Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of intramuscularly administered morphine in horses.
    Devine EP; KuKanich B; Beard WL
    J Am Vet Med Assoc; 2013 Jul; 243(1):105-12. PubMed ID: 23786198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
    Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study.
    Cerchietti LC; Navigante AH; Körte MW; Cohen AM; Quiroga PN; Villaamil EC; Bonomi MR; Roth BM
    Pain; 2003 Sep; 105(1-2):265-73. PubMed ID: 14499444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
    J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical morphine for oral mucositis in children: dose finding and absorption.
    Nielsen BN; Aagaard G; Henneberg SW; Schmiegelow K; Hansen SH; Rømsing J
    J Pain Symptom Manage; 2012 Jul; 44(1):117-23. PubMed ID: 22658469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer.
    Mashayekhi SO; Ghandforoush-Sattari M; Routledge PA; Hain RD
    Biopharm Drug Dispos; 2009 Apr; 30(3):99-106. PubMed ID: 19260034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.
    Smith MT; Wright AW; Williams BE; Stuart G; Cramond T
    Anesth Analg; 1999 Jan; 88(1):109-16. PubMed ID: 9895076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rectal controlled-release morphine: plasma levels of morphine and its metabolites following the rectal administration of MST Continus 100 mg.
    Campbell WI
    J Clin Pharm Ther; 1996 Apr; 21(2):65-71. PubMed ID: 8809641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
    Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
    Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.